Patents by Inventor Barry J. Linder
Barry J. Linder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11947197Abstract: A wearable optical device increases a Resolvable Object Distance Range (RODR) thereby reducing focusing demands of a plurality of objects located along a visual angle distance for a user with presbyopia or myopia. The devise includes a negative refractive element and a positive refractive element located along an optical axis. The negative refractive element and the positive refractive element are separated from each other by a separation space and at a separation distance suitable for mounting on a spectacle. A surface of a non-central zone of the negative refractive element or the positive refractive element is a Fresnel surface. The separation space is filled by an intermediate media with a refractive index lower than that of the negative refractive element or the positive refractive element. In one embodiment, the intermediate media is an optical grade resin or polymer.Type: GrantFiled: February 12, 2021Date of Patent: April 2, 2024Assignee: REOPIA OPTICS, INC.Inventors: Yan Zhou, Barry J. Linder
-
Publication number: 20240091067Abstract: Embodiments provide a moldable warming device is configured to provide, using a heating disc, therapeutic warmth and, using a harmonic RFSVG, tuned harmonic resonance frequency stimulation vibration according to determined tuning parameters across the contour of the entire surface of the user's eyelid and periorbital structures to induce expression of shear thinned and liquified meibum from each Meibomian gland in all four eyelids to improve the lipid layer of the surface of the user's eye tear film. According to an embodiment, the moldable warming device further includes a pair of removable and reusable eye pads, each eye pad including a miniaturized optical coherence tomography device configured to map, in real-time, a topography of the user's periocular surface, including a mapping of the eyes and the nose including interpupillary distance and corneal apex height above the lateral canthus to optimize conformance of the pair of eye pads to the periocular surface of the user's eyelids.Type: ApplicationFiled: November 29, 2023Publication date: March 21, 2024Applicant: EYEDETEC MEDICAL, INC.Inventors: Barry J. LINDER, Ronald D. LINDER, James L. DIPPO, Rubin D. LINDER, John A. SCHOLL, Vance THOMPSON
-
Patent number: 11187921Abstract: Spectacles that control myopia progression have a central zone that achieves foveal vision correction and distributed micro-reticle(s) and corresponding micro-lens(es) around the paracentral and/or peripheral zone of the spectacle. Each micro-lens is disposed between its corresponding micro-reticle and the pupil of a wearer's eye. The micro-reticle(s) and micro-len(s) are integrated with the structure of the spectacle to partially block some of the paracentral and/or peripheral objects from surrounding optical environment. The rest of the paracentral and/or peripheral retinal areas are still available for a wearer's eye to sense the presence and movement of surrounding objects.Type: GrantFiled: September 25, 2019Date of Patent: November 30, 2021Assignee: REOPIA OPTICS, LLC.Inventors: Yan Zhou, Barry J. Linder
-
Publication number: 20210231977Abstract: A wearable optical device increases a Resolvable Object Distance Range (RODR) thereby reducing focusing demands of a plurality of objects located along a visual angle distance for a user with presbyopia or myopia. The devise includes a negative refractive element and a positive refractive element located along an optical axis. The negative refractive element and the positive refractive element are separated from each other by a separation space and at a separation distance suitable for mounting on a spectacle. A surface of a non-central zone of the negative refractive element or the positive refractive element is a Fresnel surface. The separation space is filled by an intermediate media with a refractive index lower than that of the negative refractive element or the positive refractive element. In one embodiment, the intermediate media is an optical grade resin or polymer.Type: ApplicationFiled: February 12, 2021Publication date: July 29, 2021Inventors: Yan Zhou, Barry J. Linder
-
Patent number: 10921612Abstract: Presbyopia treatment and anti-myopia spectacles comprise a negative refractive element facing an object and a positive refractive element facing a patient eye. The negative refractive element has a central zone with a strong negative refractive power. The positive refractive element has a central zone with a less strong positive refractive power. The front focal point of the central zone of the positive lens does not have to overlap with the front focal point of the central zone of the negative lens. The negative refractive element and the positive refractive element are axially separated by a relatively small distance such that the combination of the two refractive elements is compact enough to be made into an easily wearable spectacle.Type: GrantFiled: March 27, 2019Date of Patent: February 16, 2021Assignee: REOPIA OPTICS, LLC.Inventors: Yan Zhou, Barry J. Linder
-
Publication number: 20200146881Abstract: Embodiments provide a moldable warming device, including a heating disc; a first harmonic resonance frequency stimulation vibration generator (RFSVG); a coupling device; a mask configured to hold the heating disc, the first harmonic RFSVG, and the coupling device for use in parallel utility; and a sensor array, the sensor array configured to determine tuning parameters of a vibration and heating profile of a user's individual eyelid, periorbital, and nasal three-dimensional anatomy and surface topography. According to at least one embodiment, the moldable warming device is configured to provide an eyelid surface and periorbital structures with therapeutic warmth, and the first harmonic RFSVG is configured to provide tuned harmonic resonance or non-resonance frequency stimulation vibration over the user's nasal bridge area through the user's nasal bone such that nasal sensory nerves are stimulated to induce tear production reflex in the user's lacrimal function unit.Type: ApplicationFiled: January 10, 2020Publication date: May 14, 2020Applicant: EYEDETEC MEDICAL, INC.Inventors: Barry J. Linder, Ronald D. Linder, James L. Dippo, Rubin D. Linder, John A. Scholl, Vance Thompson
-
Publication number: 20200089023Abstract: Spectacles that control myopia progression have a central zone that achieves foveal vision correction and distributed micro-reticle(s) and corresponding micro-lens(es) around the paracentral and/or peripheral zone of the spectacle. Each micro-lens is disposed between its corresponding micro-reticle and the pupil of a wearer's eye. The micro-reticle(s) and micro-len(s) are integrated with the structure of the spectacle to partially block some of the paracentral and/or peripheral objects from surrounding optical environment. The rest of the paracentral and/or peripheral retinal areas are still available for a wearer's eye to sense the presence and movement of surrounding objects.Type: ApplicationFiled: September 25, 2019Publication date: March 19, 2020Inventors: Yan Zhou, Barry J. Linder
-
Publication number: 20190302481Abstract: Presbyopia treatment and anti-myopia spectacles comprise a negative refractive element facing an object and a positive refractive element facing a patient eye. The negative refractive element has a central zone with a strong negative refractive power. The positive refractive element has a central zone with a less strong positive refractive power. The front focal point of the central zone of the positive lens does not have to overlap with the front focal point of the central zone of the negative lens. The negative refractive element and the positive refractive element are axially separated by a relatively small distance such that the combination of the two refractive elements is compact enough to be made into an easily wearable spectacle.Type: ApplicationFiled: March 27, 2019Publication date: October 3, 2019Inventors: Yan Zhou, Barry J. Linder
-
Publication number: 20190142677Abstract: Embodiments provide cloud-based ophthalmic eyelid treatment monitoring systems and cloud-based methods for monitoring ophthalmic eyelid treatment. The monitoring system includes a moldable warming device, a monitor, and a cloud server. The moldable warming device includes a heating disc, a resonance frequency stimulation vibration generator (RFSVG), a coupling device, a mask, and a sensor array. The mask is configured to hold the heating disc, the RFSVG, and the coupling device for use in parallel utility. The sensor array is configured to generate a data stream responsive to a vibration and heating profile of a user's individual patient eyelid and periorbital three-dimensional anatomy and surface topography. The monitor is configured to receive the data stream from the sensor array and configured to transmit the data stream to the cloud server.Type: ApplicationFiled: January 10, 2019Publication date: May 16, 2019Applicant: EYEDETEC MEDICAL, INC.Inventors: Barry J. LINDER, Ronald D. LINDER, James L. DIPPO, Rubin D. LINDER, John A. SCHOLL
-
Publication number: 20190029878Abstract: Embodiments provide a moldable warming device. The moldable warming device includes a heating disc, a harmonic resonance frequency stimulation vibration generator (RFSVG), a coupling device, a mask, and a sensor array. The mask is configured to hold the heating disc, the RFSVG, and the coupling device for use in parallel utility. The sensor array is configured to determine tuning parameters of a vibration and heating profile of a user's individual eyelid and periorbital three-dimensional anatomy and surface topography. The moldable warming device is configured to provide an entire eyelid surface and periorbital structures with therapeutic warmth and tuned harmonic resonance frequency stimulation vibration to mobilize Meibom lipids and stimulate flow of the mobilized Meibom lipids from the user's Meibomian glands.Type: ApplicationFiled: September 28, 2018Publication date: January 31, 2019Applicant: EYEDETEC MEDICAL, INC.Inventors: Barry J. LINDER, Ronald D. LINDER, James L. DIPPO, Rubin D. LINDER, John A. SCHOLL
-
Publication number: 20150216615Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: ApplicationFiled: January 12, 2015Publication date: August 6, 2015Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder, Rene Vargas-Voracek
-
Patent number: 8965088Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: GrantFiled: January 17, 2014Date of Patent: February 24, 2015Assignee: ConforMIS, Inc.Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder
-
Patent number: 8932363Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: GrantFiled: November 7, 2003Date of Patent: January 13, 2015Assignee: ConforMIS, Inc.Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder
-
Publication number: 20140153798Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: ApplicationFiled: January 17, 2014Publication date: June 5, 2014Applicant: ConforMIS, Inc.Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder
-
Patent number: 8721572Abstract: Modularized eye treatment devices, systems, kits and method are disclosed which include therapy delivery modules that are combined in a housing to deliver one or more therapies to a patient. Therapy modules include temperature control modules, moisture delivery modules and massage delivery modules. A controller can be provided that identifies which therapy modules are provided and therapy is adjusted based on the identification of which modules are provided in the housing.Type: GrantFiled: June 10, 2011Date of Patent: May 13, 2014Assignee: Eyedetec Medical, Inc.Inventors: Barry J. Linder, Robert Sykora
-
Patent number: 8634617Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: GrantFiled: December 6, 2011Date of Patent: January 21, 2014Assignee: ConforMIS, Inc.Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder
-
Publication number: 20120093377Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: ApplicationFiled: December 6, 2011Publication date: April 19, 2012Applicant: ConforMIS, Inc.Inventors: Konstantinos TSOUGARAKIS, Daniel STEINES, Bhaskar Rao VISSA, Philipp LANG, Barry J. LINDER
-
Patent number: 8077950Abstract: The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.Type: GrantFiled: August 10, 2010Date of Patent: December 13, 2011Assignee: ConforMIS, Inc.Inventors: Konstantinos Tsougarakis, Daniel Steines, Bhaskar Rao Vissa, Philipp Lang, Barry J. Linder
-
Patent number: 8073521Abstract: Described herein are methods for analyzing bone structure and/or bone density, methods for estimating fracture risk in a subject as well as methods for monitoring the efficacy of an agent on bone structure and/or bone density.Type: GrantFiled: September 17, 2004Date of Patent: December 6, 2011Assignee: ImaTx, Inc.Inventors: Siau-Way Liew, Rene Vargas-Voracek, Philipp Lang, Claude D. Arnaud, Daniel Steines, Barry J. Linder
-
Publication number: 20110046581Abstract: This invention is directed to a therapeutic patch for ophthalmologic and cosmetic use that provides therapy to the region where the patch is provided; the therapeutic patch provides a therapeutic delivery surface for placement against, for example, the eyelid and peri-orbital structures of a patient, and a non-contacting surface that can be used, for example, to generate heat and/or moisture for transmission to the surface to which therapy is being applied. The invention also includes a kit for at-home care of a region requiring therapy, in a manner that inhibits transmission of infectious agents.Type: ApplicationFiled: September 3, 2010Publication date: February 24, 2011Inventor: Barry J. Linder